메뉴 건너뛰기




Volumn 18, Issue 1, 2014, Pages 110-113

Dilated cardiomyopathy and hypothyroidism associated with pegylated interferon and ribavirin treatment for chronic hepatitis C: Case report and literature review

Author keywords

Adverse drug reaction; Cardiotoxicity; Pegylated interferon; Thyroid dysfunction

Indexed keywords

ALPHA2B INTERFERON; AMINOTRANSFERASE; ANTINUCLEAR ANTIBODY; BENAZEPRIL; DIGOXIN; FUROSEMIDE; LEVOTHYROXINE; LIOTHYRONINE; METOPROLOL SUCCINATE; PEGINTERFERON ALPHA2B; RIBAVIRIN; THYROGLOBULIN ANTIBODY; THYROTROPIN; THYROXINE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; METOPROLOL; PEGINTERFERON ALPHA2A; SUCCINIC ACID; THYROID PEROXIDASE ANTIBODY; VIRUS RNA;

EID: 84893644466     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2013.05.014     Document Type: Article
Times cited : (14)

References (17)
  • 1
    • 0035811625 scopus 로고    scopus 로고
    • Hepatitis C virus infection
    • Lauer G.M., Walker B.D. Hepatitis C virus infection. N Engl J Med 2001, 345:41-52.
    • (2001) N Engl J Med , vol.345 , pp. 41-52
    • Lauer, G.M.1    Walker, B.D.2
  • 2
    • 84856439885 scopus 로고    scopus 로고
    • Thyroid disorders in patients with chronic hepatitis C using interferon alpha and ribavirin therapy
    • Andrade L.J., Atta A.M., Atta M.L., Mangabeira C.N., Parana R. Thyroid disorders in patients with chronic hepatitis C using interferon alpha and ribavirin therapy. Braz J Infect Dis 2011, 15:377-381.
    • (2011) Braz J Infect Dis , vol.15 , pp. 377-381
    • Andrade, L.J.1    Atta, A.M.2    Atta, M.L.3    Mangabeira, C.N.4    Parana, R.5
  • 3
    • 84867516587 scopus 로고    scopus 로고
    • Thyroid dysfunction in Chinese patients with chronic hepatitis C treated with interferon alpha: incidence, long-term outcome and predictive factors
    • Yan Z., Fan K., Fan Y., et al. Thyroid dysfunction in Chinese patients with chronic hepatitis C treated with interferon alpha: incidence, long-term outcome and predictive factors. Hepat Mon 2012, 12:e6390.
    • (2012) Hepat Mon , vol.12
    • Yan, Z.1    Fan, K.2    Fan, Y.3
  • 4
    • 59249092117 scopus 로고    scopus 로고
    • Evolution and predictive factors of thyroid disorder due to interferon alpha in the treatment of hepatitis C
    • Gelu-Simeon M., Burlaud A., Young J., Pelletier G., Buffet C. Evolution and predictive factors of thyroid disorder due to interferon alpha in the treatment of hepatitis C. World J Gastroenterol 2009, 15:328-333.
    • (2009) World J Gastroenterol , vol.15 , pp. 328-333
    • Gelu-Simeon, M.1    Burlaud, A.2    Young, J.3    Pelletier, G.4    Buffet, C.5
  • 6
    • 82855169549 scopus 로고    scopus 로고
    • Virus C genotype predisposes to primary hypothyroidism during interferon-alpha treatment for chronic hepatitis C
    • Pavan M.H., Pavin E.J., Gonçales F.L., Wittmann D.E. Virus C genotype predisposes to primary hypothyroidism during interferon-alpha treatment for chronic hepatitis C. Braz J Infect Dis 2011, 15:449-456.
    • (2011) Braz J Infect Dis , vol.15 , pp. 449-456
    • Pavan, M.H.1    Pavin, E.J.2    Gonçales, F.L.3    Wittmann, D.E.4
  • 7
    • 0026026353 scopus 로고
    • Cardiotoxicity of interferon. A review of 44 cases
    • Sonnenblick M., Rosin A. Cardiotoxicity of interferon. A review of 44 cases. Chest 1991, 99:557-561.
    • (1991) Chest , vol.99 , pp. 557-561
    • Sonnenblick, M.1    Rosin, A.2
  • 8
    • 0030473452 scopus 로고    scopus 로고
    • Adverse effects of interferon on the cardiovascular system in patients with chronic hepatitis C
    • Teragawa H., Hondo T., Amano H., Hino F., Ohbayashi M. Adverse effects of interferon on the cardiovascular system in patients with chronic hepatitis C. Jpn Heart J 1996, 37:905-915.
    • (1996) Jpn Heart J , vol.37 , pp. 905-915
    • Teragawa, H.1    Hondo, T.2    Amano, H.3    Hino, F.4    Ohbayashi, M.5
  • 9
    • 79953171208 scopus 로고    scopus 로고
    • Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - case report
    • Popescu C., Arama V., Gliga S. Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - case report. BMC Gastroenterol 2011, 11:30.
    • (2011) BMC Gastroenterol , vol.11 , pp. 30
    • Popescu, C.1    Arama, V.2    Gliga, S.3
  • 10
    • 84866271740 scopus 로고    scopus 로고
    • Pericardial effusion and tamponade following interferon alpha treatment for locally advanced melanoma
    • Rauw J., Ahmed S., Petrella T. Pericardial effusion and tamponade following interferon alpha treatment for locally advanced melanoma. Med Oncol 2012, 29:1304-1307.
    • (2012) Med Oncol , vol.29 , pp. 1304-1307
    • Rauw, J.1    Ahmed, S.2    Petrella, T.3
  • 11
    • 0023685381 scopus 로고
    • Recombinant alpha 2 interferon-related cardiomyopathy
    • Cohen M.C., Huberman M.S., Nesto R.W. Recombinant alpha 2 interferon-related cardiomyopathy. Am J Med 1988, 85:549-551.
    • (1988) Am J Med , vol.85 , pp. 549-551
    • Cohen, M.C.1    Huberman, M.S.2    Nesto, R.W.3
  • 12
    • 33644590228 scopus 로고    scopus 로고
    • Fatal cardiomyopathy associated with pegylated interferon/ribavirin in a patient with chronic hepatitis C
    • Condat B., Asselah T., Zanditenas D., et al. Fatal cardiomyopathy associated with pegylated interferon/ribavirin in a patient with chronic hepatitis C. Eur J Gastroenterol Hepatol 2006, 18:287-289.
    • (2006) Eur J Gastroenterol Hepatol , vol.18 , pp. 287-289
    • Condat, B.1    Asselah, T.2    Zanditenas, D.3
  • 14
    • 0034619028 scopus 로고    scopus 로고
    • Adverse drugs reactions: definitions, diagnosis, and management
    • Edwards I.R., Aronson J.K. Adverse drugs reactions: definitions, diagnosis, and management. Lancet 2000, 356:1255-1259.
    • (2000) Lancet , vol.356 , pp. 1255-1259
    • Edwards, I.R.1    Aronson, J.K.2
  • 15
    • 84874023278 scopus 로고    scopus 로고
    • Is combination therapy for chronic hepatitis C toxic for cardiac functionα
    • Almawardy R., Elhammady W., Mousa N., Abotaleb Sh. Is combination therapy for chronic hepatitis C toxic for cardiac functionα. Hepat Mon 2012, 12:e6254.
    • (2012) Hepat Mon , vol.12
    • Almawardy, R.1    Elhammady, W.2    Mousa, N.3    Abotaleb, S.4
  • 16
    • 79953285607 scopus 로고    scopus 로고
    • Safety and efficacy of peginterferon alpha plus ribavirin in patients with chronic hepatitis C and coexisting heart disease
    • Durante-Mangoni E., Iossa D., Pinto D., De Vincentiis L., Ragone E., Utili R. Safety and efficacy of peginterferon alpha plus ribavirin in patients with chronic hepatitis C and coexisting heart disease. Dig Liver Dis 2011, 43:411-415.
    • (2011) Dig Liver Dis , vol.43 , pp. 411-415
    • Durante-Mangoni, E.1    Iossa, D.2    Pinto, D.3    De Vincentiis, L.4    Ragone, E.5    Utili, R.6
  • 17
    • 84866849352 scopus 로고    scopus 로고
    • Thyroid dysfunction in Turkish patients with chronic hepatitis C receiving peginterferon plus ribavirin in the period of 2005-2010
    • Barut S., Gunal O., Erkorkmaz U., Yildiz F. Thyroid dysfunction in Turkish patients with chronic hepatitis C receiving peginterferon plus ribavirin in the period of 2005-2010. Braz J Infect Dis 2012, 16:448-451.
    • (2012) Braz J Infect Dis , vol.16 , pp. 448-451
    • Barut, S.1    Gunal, O.2    Erkorkmaz, U.3    Yildiz, F.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.